Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

被引：0
作者：
Edward Sausville
Patricia LoRusso
Michael Carducci
Judith Carter
Mary F. Quinn
Lisa Malburg
Nilofer Azad
David Cosgrove
Richard Knight
Peter Barker
Sonya Zabludoff
Felix Agbo
Patricia Oakes
Adrian Senderowicz
机构：
[1] University of Maryland,Marlene and Stewart Greenebaum Cancer Center
[2] Wayne State University School of Medicine,Karmanos Cancer Center
[3] Johns Hopkins Medical Institutions,Sidney Kimmel Comprehensive Cancer Center
[4] AstraZeneca,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
AZD7762; Chk1; Solid tumors; Phase I; Safety; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：539 / 549
页数：10
相关论文
共 50 条
[21]   A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium [J].
Lheureux, S. ;
Oza, A. M. ;
Laurie, S. A. ;
Halford, R. ;
Jonker, D. ;
Chen, E. ;
Keller, D. ;
Bourade, V. ;
Wang, L. ;
Doyle, L. ;
Siu, L. L. ;
Goel, R. .
BRITISH JOURNAL OF CANCER, 2015, 113 (11) :1534-1540
[22]   A phase I combination dose-escalation study of eribulin mesylate and gemcitabine in patients with advanced solid tumours: a study of the Princess Margaret Consortium [J].
S Lheureux ;
A M Oza ;
S A Laurie ;
R Halford ;
D Jonker ;
E Chen ;
D Keller ;
V Bourade ;
L Wang ;
L Doyle ;
L L Siu ;
R Goel .
British Journal of Cancer, 2015, 113 :1534-1540
[23]   A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors [J].
Plummer, Ruth ;
Madi, Ayman ;
Jeffels, Melinda ;
Richly, Heike ;
Nokay, Bahar ;
Rubin, Stephen ;
Ball, Howard A. ;
Weller, Steve ;
Botbyl, Jeffrey ;
Gibson, Diana M. ;
Scheulen, Max E. .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) :93-101
[24]   A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors [J].
Ruth Plummer ;
Ayman Madi ;
Melinda Jeffels ;
Heike Richly ;
Bahar Nokay ;
Stephen Rubin ;
Howard A. Ball ;
Steve Weller ;
Jeffrey Botbyl ;
Diana M. Gibson ;
Max E. Scheulen .
Cancer Chemotherapy and Pharmacology, 2013, 71 :93-101
[25]   Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors [J].
Sun, Yongkun ;
Yang, Lin ;
Hao, Xuezhi ;
Liu, Yutao ;
Zhang, Jinwen ;
Ning, Zhiqiang ;
Shi, Yuankai .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
[26]   A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma [J].
Hollebecque, A. ;
Deutsch, E. ;
Massard, C. ;
Gomez-Roca, C. ;
Bahleda, R. ;
Ribrag, V. ;
Bourgier, C. ;
Lazar, V. ;
Lacroix, L. ;
Gazzah, A. ;
Varga, A. ;
de Baere, T. ;
Beier, F. ;
Kroesser, S. ;
Trang, K. ;
Zenke, F. T. ;
Klevesath, M. ;
Soria, Jean-Charles .
INVESTIGATIONAL NEW DRUGS, 2013, 31 (06) :1530-1538
[27]   Phase I dose-escalation study of chiauranib, a novel angiogenic, mitotic, and chronic inflammation inhibitor, in patients with advanced solid tumors [J].
Yongkun Sun ;
Lin Yang ;
Xuezhi Hao ;
Yutao Liu ;
Jinwen Zhang ;
Zhiqiang Ning ;
Yuankai Shi .
Journal of Hematology & Oncology, 12
[28]   A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma [J].
A. Hollebecque ;
E. Deutsch ;
C. Massard ;
C. Gomez-Roca ;
R. Bahleda ;
V. Ribrag ;
C. Bourgier ;
V. Lazar ;
L. Lacroix ;
A. Gazzah ;
A. Varga ;
T. de Baere ;
F. Beier ;
S. Kroesser ;
K. Trang ;
F. T. Zenke ;
M. Klevesath ;
Jean-Charles Soria .
Investigational New Drugs, 2013, 31 :1530-1538
[29]   Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors [J].
Schwartz, Gary K. ;
Carvajal, Richard D. ;
Midgley, Rachel ;
Rodig, Scott J. ;
Stockman, Paul K. ;
Ataman, Ozlem ;
Wilson, David ;
Das, Shampa ;
Shapiro, Geoffrey I. .
INVESTIGATIONAL NEW DRUGS, 2013, 31 (02) :370-380
[30]   Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors [J].
Aspeslagh, Sandrine ;
Awada, Ahmad ;
Matos-Pita, Arturo S. ;
Aftimos, Philippe ;
Bahleda, Ratislav ;
Varga, Andrea ;
Soria, Jean-Charles .
ANTI-CANCER DRUGS, 2016, 27 (10) :1021-1027
12345